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FGFryonic development is to deﬁne how different signals cooperate in generating
unique cell types. To address this issue, we focused on the function and the regulation of the proneural gene
Neurogenin2 (Neurog2) during early mouse spinal neurogenesis. We showed that Neurog2 is ﬁrst expressed in
cells within the neural plate anterior to the node from the 5 somite-stage. The analysis of Neurog2 mutants
established a role for this gene in triggering neural differentiation during spinal cord elongation. We
identiﬁed a 798 base pair enhancer element (Neurog2-798) upstream of the Neurog2 coding sequence that
directs the early caudal expression of Neurog2. Embryo culture experiments showed that Retinoic Acid (RA),
Sonic hedgehog (Shh) and Fibroblast Growth Factor signals act in concert on this enhancer to control the
spatial and temporal induction of Neurog2. We further demonstrated by transgenesis that two RA response
elements and a Gli binding site within the Neurog2-798 element are absolutely required for its activity,
strongly suggesting that the regulation of Neurog2 early expression by RA and Shh signals is direct. Our data
thus support a model where signal integration at the level of a single enhancer constitutes a key mechanism
to control the onset of neurogenesis.
© 2008 Elsevier Inc. All rights reserved.IntroductionDuring chick and mouse development, epiblast cells lying adjacent
to the anterior primitive streak give rise to spinal cord progenitors
(Brown and Storey, 2000; Cambray andWilson, 2002, 2007; Mathis et
al., 2001;Mathis and Nicolas, 2000). This region can be considered as a
stem zone containing self-renewing progenitors which contribute to
the formation of the spinal cord as the node regresses (Mathis and
Nicolas, 2000). Fibroblast Growth Factor (FGF) signalling maintains
the integrity and the undifferentiated state of progenitors within this
region (Ciruna and Rossant, 2001; Mathis et al., 2001). From
embryonic day 8 in the mouse (E8), some progenitors escape the
inﬂuence of high FGF signalling (Mathis et al., 2001), reside transiently
in the neural plate anterior to the node (also called pre-neural tube
(pNT); Diez del Corral et al., 2002) and then populate the newly
formed spinal cord. In this location the process of neurogenesis isand Development, CNRS URA
5 rue du Dr. Roux 75724 Cedex
ology, NIMR, the RidgewayMill
MR 8090, 1 rue du Pr. Calmette,
l rights reserved.initiated. Spinal progenitors then acquire (i) markers of the dorso-
ventral (DV) axis including homeodomain (HD) and basic helix–loop–
helix (bHLH) containing genes (for example, Pax6 and Olig2,
respectively) (ii) generic neuronal features mediated by a cascade of
proneural bHLH transcription factors (Bertrand et al., 2002; Guillemot,
2007; Lupo et al., 2006). In parallel, progenitors identity along the
antero-posterior (AP) axis, assigned in part by the combination of Hox
genes they expressed, is stabilized and reﬁned (e.g. Stern et al., 2006).
The initiation of these events is temporally and spatially regulated
by multiple signalling pathways emanating from the node, the
paraxial and axial mesoderm (Diez del Corral and Storey, 2004).
Hence, convergent activities of FGFs, Glial cell line-derived neuro-
trophic factor (Gdnf11) and Retinoic Acid (RA) signals establish and
reﬁne the Hox-c-dependent positional identity of motor neurons (Liu
et al., 2001). In parallel, RA and Sonic hedgehog (Shh) signalling
pathways promote the emergence of a ventral expression pattern of
homeodomain containing genes while FGF signalling represses these
genes (Bertrand et al., 2000; Diez del Corral et al., 2002; 2003;
Molotkova et al., 2005; Novitch et al., 2003; Wilson et al., 2004). Some
evidence suggests that the initial steps of neurogenesis rely on
multiple cross-interactions between these signalling pathways. How-
ever, the molecular mechanisms underlying such cross-talk remain an
open question. For instance, the speciﬁcation of motor neuron
progenitors in response to Shh requires an active state of retinoic
signalling (Novitch et al., 2003). Other data suggest that the effects of
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mediated in part by a repression of the expression of some of the
components of the RA and Shh signalling pathways. Indeed, FGFs
induce a downregulation of the expression of Retinaldehyde dehy-
drogenase 2 (Raldh2) encoding for an enzyme responsible for all RA
synthesis in the early mouse embryo, Retinoic acid receptor β (Rarβ),
Shh itself and Patched2 (Ptch2) encoding for one of the Shh receptors
(Diez del Corral et al., 2003; Olivera-Martinez and Storey, 2007).
To better understand how signalling pathways converge to trigger
early steps of spinal cord development, we focused our study on the
function and regulation of the proneural gene Neurogenin2 (Neurog2).
This gene plays essential roles during spinal neurogenesis. First, it is
involved in controlling the timingof neural differentiation (Mizuguchi et
al., 2001;Novitchet al., 2001; Scardigli et al., 2001). This activity depends
on the ability of Neurog2 to suppress the expression of Sox2 and Sox3
genes, possibly by inducing the vertebrate ortholog of the ﬂy gcm
(Bergsland et al., 2006; Bylund et al., 2003; Sandberg et al., 2005;
Soustelle et al., 2007). In additionNeurog2 activates SoxC geneswhich in
turn regulate the expression of pan-neuronal proteins (Bergsland et al.,
2006). Second, Neurog2 inﬂuences the generation of speciﬁc neural
subtypes. Forexample, in themotorneuronprogenitordomainNeurog2,
together with Olig2, promotes motor neuron differentiation. According
to the current model, the choice between differentiating into a motor
neuron or remaining a progenitor depends on the ratio of Olig2
repressor to Neurog2 activator (Lee et al., 2005; Lu et al., 2002;
Mizuguchi et al., 2001; Novitch et al., 2001; Scardigli et al., 2001; Zhou
and Anderson, 2002). Furthermore, the role of Neurog2 in specifying
motor neurons relies in part on GSK3mediated phosphorylations of the
protein which allow the binding of Neurog2 to LIM homeodomain
transcription factors. Notably, this post-translational modiﬁcation is not
required for its ability to induce neural differentiation (Ma et al., 2008).
Although Neurog2 function has been widely analysed, the time of
its onset and its early function remained unknown. In this study, we
show that Neurog2 is ﬁrst expressed in the E8.5 mouse embryo, within
the neural plate anterior to the node where it controls the onset of
spinal neurogenesis. We demonstrate that this early expression is
driven by a single enhancer and that its activity is modulated in a
combinatorial manner by RA, Shh and FGF signals. Furthermore we
show that RA and Shh signalling pathways regulate Neurog2 early
expression via two RA response elements and one Gli binding site.
Materials and methods
Mouse lines and generation of transgenic mice
Mice heterozygous for the Neurog2KIlacZ allele (Fode et al., 2000)
were intercrossed to generate homozygous mutant embryos.
Neurog2-E2:: lacZ transgenic mice have been described (Scardigli
et al., 2001). Mice carrying the Shh mutation and the Rare-lacZ
transgene were kindly provided R. Zeller and J. Rossant respectively.
Transgenic mice were generated by standard procedures using
fertilized eggs from FVBN embryos and founder animals were geno-
typed as described (Scardigli et al., 2001).
Neurog2-E2.1, Neurog2-E2.2, Neurog2-E2.3, Neurog2-E2.4 and
Neurog2-798 sequences were ampliﬁed by PCR, a NotI and a SpeI
restriction sites (underlined, see below) were added at the end of the
5Vand 3Voligonucleotides respectively, to allowcloning of the resulting
PCR fragment into the βglobin-lacZ plasmid (Yee and Rigby, 1993).
Numbers give the coordinate of the ﬁrst base pair of the oligonucleo-
tide based on the NCBI Mus musculus genome build 37.1 on
chromosome 3.
E2.1 (fw) ATAAGAATGCGGCCGCCGGGAGAGCCAGCTCC (127, 329,
157)
(rev) GGACTAGTCCACTGCCTCAAGCCTCGGAGTGTGC (127, 330,
867)E2.2 (fw) ATAAGAATGCGGCCGCACTTACCAGACCTGG (127, 330, 795)
(rev) GGACTAGTCTCGTCTCTGTCTAATCCTCTC (127, 332, 571)
E2.3 (fw) ATAAGAATGCGGCCGCAAGTTCCAGACCAGTC (127, 332, 571)
(rev) GGACTAGTGTCATCTGGGACCGGTCGCGGC (127, 334, 660)
E2.4 (fw) ATAAGAATGCGGCCGCGACCGGTCCCAG (127, 334, 636)
(rev) GGACTAGTCACTGCGTCTAGAGCGATGG (127, 336, 446)
798 (fw) ATAAGAATGCGGCCGCTAACTTAACTTTCTCGCC (12, 331, 316)
(rev) GGACTAGTTTCACTGAGAAAACGAAAAGGC (127, 332, 114)
In order to replace the βglobin promoter by the endogenous
Neurog2 promoter, two complementary oligonucleotides harbouring
SpeI and NcoI restriction (underlined, see below) at the 5′ and 3′ end
respectively and corresponding to the conserved sequence (72 bp)
around the TATA box between the human, chimpanzee, rat andmouse
Neurog2 regulatory sequence were hybridised and cloned into the
Neurog2-798 βglobin-lacZ plasmid.
(fw) CTAGTGAGGAGGGGGCCCCGGGGCAGATCTGATTGTTTT-
CTTGGTGGTATATAA
GGGGTTTTAAGGAGAGTCGTGTGC
(rev) CATGGCTCACGACTCTCCTTAAAACCCCTTATATACCACCAAGAAAA-
CAATCAGA
TCTGCCCCGGGGCCCCCTCCTCA
The design of null point mutations in the putative the Rares, the Gli
and Cdx binding sites (BS) have been made according to Charite et al.,
1998; Gustafsson et al., 2002; Marshall et al., 1994; the mutated bases
appear in red:Rare DR2 (fw) GCCCGCTTCGACATTTGTACTTCTTAAAGTAGGATTGC
(rev) ATCCTACTTTAAGAAGTACAAATGTCGAAGCGGGC
Rare DR5 (fw) TTTAGACAAGTACCGCTAATGTCGGGCGCGG
(rev) GCGCCCGACATTAGCGGTACTTGTCTAAAGG
Gli BS (fw) GCAAACTTTCAGACTGCAGAAGTGCCTCTTG
(rev) CAAGAGGCACTTCTGCAGTCTGAAAGTTTGC
Cdx BS (fw) GTGCCTCTTGAATTTACCCAAGTTAAAAGAGTGC
(rev) CTTTTAACTTGGGTAAATTCAAGAGGCACTTGTGTGG
The generation of point mutations was achieved by two rounds of
PCR using internal oligonucleotides containing the appropriate muta-
tions and external oligonucleotides used to amplify the Neurog2-798
element. The mutation of the two Rares has been done sequentially.
The sequences of the PCR ampliﬁcation products were checked by
sequencing.
Embryos culture experiments
Pregnant females were sacriﬁced at E8 and dissected embryos
with intact yolk sacs were cultured in culture medium (rat serum,
tyrode solution; 1:1) in 5 ml tubes (1 ml medium/tube; 8–10
embryos/tube). Recombinant mouse Shh-N (R and D systems) was
rehydrated in culture medium at 2.5 μM. SU5402 (Calbiochem) and
BMS493 (Bristol-Myers-Squibb) were dissolved in DMSO at 85 mM
and 5 mM, respectively. Cyclopamine (LC laboratories) was rehy-
drated in a 45% solution of hydroxypropyl-beta-cyclodestrin (HBC,
Sigma) in phosphate buffer at 2.42 mM. All-trans-RA (AT-RA;
Biomol) was dissolved in 95% EtOH at 20 mM. For each drug,
control embryos were cultured in presence of the drug's vehicle at
the appropriate concentration. The efﬁcacy of each drug was tested
by analyzing the expression of target genes for each signalling
pathways (Suppl. Fig. 2). Cultures were performed in a water-
saturated roller-tube incubator at 37 °C, 5% CO2 and 20% O2. After
culture, the embryos were ﬁxed overnight at 4 °C in 4% para-
formaldehyde and processed for in situ hybridization analysis. Gene
expression patterns were always compared between embryos
processed in the same culture experiment.
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Whole-mount in situ hybridizations were performed using an
Intavis InSitu Pro robot (http://www.eumorphia.org/EMPReSS/servlet/
EMPReSS.Frameset). Gene expression patterns were always compared
between embryos processed in the same robotic run. The probes used
for in situ hybridisation were the following: Neurog2 (Gradwohl et al.,
1996); lacZ (Bonnerot et al., 1987); Dll1 (Bettenhausen et al., 1995);
Hes5 (Akazawa et al., 1992); Olig2 (Zhou and Anderson, 2002).
For immunochemistry, early somite-stage embryos were ﬁxed in
4% paraformaldehyde for 30 min at 4 °C and were processed for
immunohistochemistry as described (Scardigli et al., 2003). Primary
antibodies incubationswere done in a solution of 10% foetal calf serum,
3% BSA in phosphate buffer. WM neuroﬁlament immunohistoche-
mistrywas performed as described (Vermot et al., 2005). The following
antibodies were used: mouse monoclonal anti-Foxa2 (Developmental
Studies Hybridoma Bank) and rabbit anti-mNeurog2 (kindly provided
by Prof.Masato Nakafuku, Cincinnati Children's Hospital;Mizuguchi et
al., 2001). Alexa 488- and Alexa 594-coupled secondary antibodies
were purchased from Molecular Probes. Whole mount embryos were
ﬂat mounted between slide and coverslip in Aquapolymount (Poly-
sciences Inc.) and analysed using a Leica M420 macroscope. The
sectioned embryos were analyzed using a Leica M420macroscope or a
Leica Sp2MP confocal microscope.
Electrophoretic mobility shift assays
EMSA were performed essentially as described (Germain et al.,
2002). For supershift assays, 1 μl of each antibody (9E10 and anti HA)
was used as described (Gustafsson et al., 2002). The following
oligonucleotides were used:
DR2-ctl (fw) TCGAGGGTAGGGGTCACAGGGTCACTCG
(rev) CGAGAGACCCTGTGACCCCTACCCTCGA
DR2-Neurog2 (fw) GCTTTGAGCTTTTGTTCTCTTAAAGTAG
(rev) CTACTTTAAGAGAACAAAAGCTCAAAGC
DR2-Neurog2 mt (fw) GCTTCGACATTTGTACTTCTTAAAGTAG
(rev) CTACTTTAAGAAGTACAAATGTCGAAGC
DR5-ctl (fw) TCGAGGGTAGGGGTCACCGAAAGGTCACTCG
(rev) CGAGTGACCTTTCGGTGACCCCTACCCTCGA
DR5-Neurog2 (fw) CCCTTTAGACAGTTCACGCTATGGACAGGCG
(rev) CGCCTGTCCATAGCGTGAACTGTCTAAAGGG
DR5-Neurog2 mt (fw) CCCTTTAGACAAGTACCGCTAATGTCGGGCG
(rev) CGCCCGACATTAGCGGTACTTGTCTAAAGGG
Gli-ctl (myf5) (fw) GGGAAAAAACGACCACCAAGAAACACAGT
(rev) ACTGTGTTTCTTGGTGGTCGTTTTTTCCC
Gli-Neurog2 (fw) CAAACTTTCAGACCACACAAGTGCCTCTT
(rev) AAGAGGCACTTGTGTGGTCTGAAAGTTTG
Gli-Neurog2 mt (fw) CAAACTTTCAGACTGCAGAAGTGCCTCTT
(rev) AAGAGGCACTTCTGCAGTCTGAAAGTTTG
Results
Neurog2 regulates the onset of spinal neurogenesis
A detailed examination of Neurog2 expression by RNA in situ
hybridization at the onset of neurogenesis in the spinal cord revealed
that this gene is ﬁrst expressed in scattered cells of the neural plate
anterior to the node (referred further as pre-neural tube, pNT) from the
5 somite-stage (5ss) onwards. We conﬁrmed the presence of Neurog2
protein among pNT cells by immunoﬂuorescence (Fig. 1D). In this
region, the progenitors are restricted to a neural fate characterized by
the expression of the pan-neuronal marker Sox2 and the absence of
mesodermal markers such as the T gene (Suppl. Fig. 1 and data not
shown, see also Delﬁno-Machin et al., 2005). However, they do not
express the ventral speciﬁcation markers such Pax6, Nkx2.2 and Olig2(Suppl. Fig. 1 and data not shown). Based on lineage analysis, cells
within the pNT contribute to the formation of the spinal cord during
the elongation of trunk structures (Cambray and Wilson, 2002, 2007;
Mathis and Nicolas, 2000). Therefore, induction of Neurog2 may
represent an early step of commitment of the self-renewing spinal
progenitors. From the 5ss onwards expression of Neurog2 is also
apparent in the prospective diencephalon (Figs.1A, A′). It then extends
to the walls of the neural tube at around 7ss, and to the hindbrain by
9ss (Figs. 1B, C).
To determine the early function of Neurog2,we examined the trunk
region of Neurog2 mutant embryos (Neurog2KILacZ/KIlacZ, further called
Neurog2−/−). We ﬁrst analysed the consequence of loss of Neurog2 on
Delta-Notch signalling (Louvi and Artavanis-Tsakonas, 2006). Dll1
expression in the caudal neuroepithelium parallels Neurog2 expres-
sion, with scattered Dll1 positive cells appearing at 5ss in the pNT and
with a delay in the neural tube (Figs. 1E, F and data not shown). In
Neurog2−/− embryos, Dll1 expression is missing from the pNT and the
spinal cord until E9.0, whereas it is still observed in the forming brain
(Figs.1G, G′). At E9.5,Dll1 remains absent from the caudal-most part of
Neurog2mutants (Fig.1H′), but Dll1 starts to be expressed in the spinal
cord at brachial level (Fig. 1H). Expression of Hes5 a Notch target and
effector, is absent from the pNT and is severely reduced in the spinal
cord of Neurog2 mutants, compared to wild type (WT) embryos, at all
stages analyzed (Figs. 1I–L′). In addition, the number of differentiated
neurons monitored by the expression of neuroﬁlament is decreased in
Neurog2−/− embryos even at brachial level (Figs. 1M–N′). Notably the
size of the ventral horn where the ﬁrst post mitotic motor neurons
migrate is severely reduced in mutants at that stage (dashed line,
Figs. 1M′–N′; see also Fig. 2, Ma et al., 2008 for a later stage). The
number of differentiated neurons in the ventral part of the neural tube
of Neurog2 mutants eventually reaches the levels of those in WT
embryos at E10.75 (Scardigli et al., 2001). This recovery is likely to be
due to the appearance in the neural tube ofNeurog1 at E9.5 both inWT
and Neurog2−/− embryos (data not shown). Therefore, Neurog2 is likely
to be the only proneural gene in the caudal region of mouse embryos
and in contrast to later stages (Scardigli et al., 2001), its function cannot
be compensated by Neurog1 at the onset of neurogenesis. Interest-
ingly, in chick the proneural genes involved in the initial steps of spinal
neurogenesis differ. Indeed, both Neurog1 and Neurog2 are excluded
from the medial pNT of chick embryos and therefore might have a
limited role in initiating the lateral inhibition process (Akai et al.,
2005). Conversely, Cash4, a chicken-speciﬁc proneural gene is
expressed within the caudal most part of this tissue and has the
capacity to induce Dll1 expression (Akai et al., 2005; Henrique et al.,
1997). Importantly, expression of Olig2, Pax6 and Nkx2.2 is similar in
early somite-stage WT and Neurog2−/− embryos (data not shown)
suggesting that Neurog2 is not required for induction of these factors.
Together these results show that in the mouse from the 5ss onwards
Neurog2 function in the pNT and the newly formed spinal cord is
necessary for the commitment and the differentiation of spinal
progenitors. In order to gain new insight into the onset of neurogenesis
we focused our study on the mechanisms that induce early expression
of Neurog2.
Multiple signals determine the onset of Neurog2 expression
We assayed for instructive factors, which act independently of
the Notch-mediated lateral inhibition process that could be involved
in the induction of Neurog2 expression (Bertrand et al. 2002). In
spite of their role in the regulation of Neurog2 expression in the
motor neuron progenitor domain (Mizuguchi et al., 2001; Novitch et
al., 2001; Scardigli et al., 2003, 2001), Pax6 and Olig2 are unlikely to
be required for Neurog2 early expression, as indicated by their
expression proﬁle which is excluded from the domain of Neurog2
induction (Suppl. Fig. 1). Moreover Neurog2 expression is maintained
in Pax6 mutant embryos (Suppl. Fig. 1; Bel-Vialar et al., 2007). We
Fig. 1. Neurog2 triggers spinal neurogenesis at early somite-stages. (A–C) In situ hybridizations (ISH) on whole mount (WM) embryos showing Neurog2 early expression. A′, B′, C′:
higher magniﬁcations of embryos in panels A–C. (D) Neurog2+ cells detected on transverse sections at the level of the pNT by immunochemistry are intermixedwith FoxA2+ cells. The
dashed line underlines the neuroepithelium. (E–L′) In Neurog2−/− mice expression of Delta1 and Hes5 monitored by ISH is absent from the pNT and appears with a delay in the
anterior spinal cord; WM embryos (E, G, I, and K) and transverse sections at brachial (F, H, J, and L) and lumbar (F′, H′, J′, and L′) levels. The arrow heads (E′, G′, I′, and K′) points to the
pNTwhere Neurog2 expression is initiated. (M, N′) A reduction in the number of differentiated neurons expressing neuroﬁlament (NF) is seen in Neurog2−/− spinal cord;WM embryos
(M, N) and transverse sections at brachial level (M′, N′), the dashed lines underlines the ventral horn. (nc) notochord; (asterisk) node; (ﬂ) forelimb; (ﬁne arrow head) diencephalon;
(ep) epibranchial placode; (thick arrow head) pNT.
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from the neural plate by culturing early somite-stage caudal
neuroepithelium from Neurog2KIlacZ/+ embryos on collagen gel. The
isolation of caudal neuroepithelium from the surrounding tissues at
the 4–7ss prevented Neurog2 induction. In contrast, culturing iso-
lated neural tube after the onset of Neurog2 expression (10–12ss)
had no effect on its expression (Suppl. Fig. 1). Therefore, Neurog2
induction, but not its maintenance, requires extrinsic factors not
present in the neuroepithelium. This result is in agreement with the
requirement of extrinsic factors for NeuroM expression in chick
spinal cord (Diez del Corral et al., 2002). This gene encodes a chicken
speciﬁc bHLH protein expressed exclusively in post-mitotic neurons
(Roztocil et al., 1997). The initiation of the whole generic neurogen-
esis program both in mouse and chick seems thus to be under the
control of cell-interactions between the neuroepithelium and the
ﬂanking mesoderm.Among the extracellular signals that regulate spinal development,
we chose to analyze the function of the RA, FGF and Shh signals in the
induction of Neurog2 expression, as the three signalling pathways
were active in the pNT (Figs. 2A–D). Indeed, pNT cells were expressing
the RA-responsive transgene, Rare-lacZ (Rossant et al., 1991), as well as
Patched 1 (Ptch1) and low levels of Sprouty2 (Spry2), two downstream
targets of Shh and FGF signalling, respectively (Goodrich et al., 1999;
Minowada et al., 1999; see also Suppl. Fig. 2). We ﬁrst assessed the
putative contribution of these signals in the regulation of Neurog2
expression by culturing early somite-stage embryos (i.e. before the
onset of Neurog2 expression) for 6 h in media containing either
agonists or antagonists of these signalling pathways. This short time
point was chosen in order to identify direct regulations of Neurog2
early expression and to minimize the indirect effects that could be
induced bymodulating developmentally important signals both on the
neuroepithelium itself or/and the adjacent tissues.
Fig. 2. RA, FGF and Shh signalling modulates Neurog2 early expression. (A–C) WM ISH for lacZ (A), Ptch1 (B) and Spry2 (C) mRNA in 5–6ss mouse embryos carrying the Rare-lacZ
transgene (A) or WT (B, C) showing respectively the presence of active RA, Shh and FGF signalling within the pNT and the forming neural tube. (D) Schematic representation of RA,
Shh and FGF activities within the caudal plate of mouse embryos. In the medial part of the pNT where Neurog2 is induced, both RA and Shh activities are initiated, whereas Fgf
signalling is fading. (E–N)WM ISH of mouse embryos collected at the 2–5ss and cultured for 6 h in the presence of drugs and hybridized with Neurog2 (E–J′; M, N) and lacZ RNA (K, L)
probes. (E, F) 2×10−7 M AT-RA induces ectopic expression of Neurog2 in the pNT and neural tube. (G, H) Conversely, blocking RA using 5×10−6 M BMS493 decreases Neurog2
expression. (I–L) Reducing FGF signalling using 5×10−5 M SU5402 increases the number of Neurog2+ cells in the pNT (I, J′) without expanding RA activity monitored by the Rare-lacZ
transgene (lacZ RNA probe) (K, L). (M, N) Reducing Shh signalling by the addition of 10−4 M cyclopamine reduces markedly Neurog2 expression. (O–R) WM ISH on Shh−/− embryos
reveals that Neurog2 is absent from the pNT and remains very weak in the neural tube compare to WT embryos. (asterisk) node; (s1) last formed somite; (ep) epibranchial placode.
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medium led to an increase in the number of Neurog2 expressing cells
within the caudal neural tube (4 embryos out of 4; 4/4) compared to
control embryos (n=3 Figs. 2E, F; see also Suppl. Fig. 2). Accordingly,
inhibition of RA activity by 5×10−6 M BMS493, a pan-Rar antagonist
(Germain et al., 2002), resulted in the absence ofNeurog2 expression in
the pNT (9/10) and in a decrease of Neurog2 expression in the neural
tube (10/10). Expression in the head and epibranchial placodes (ep)
was however unaffected (Figs. 2G, H; see also Suppl. Fig. 2). These
results are in agreement with the ﬁnding that Neurog2 expression is
absent in the spinal cord of RA deﬁcient embryos (Diez del Corral et al.,
2003; Novitch et al., 2003; VR, ILR, PD in preparation). We then
assessed the role of FGF signalling in regulating Neurog2 expression by
adding 5×10−5 M SU5402, an FGF receptor inhibitor to the culture
medium (Mohammadi et al., 1997). Neurog2 expression in the spinal
cord was comparable in treated (n=11) and untreated (n=16) embryos
(Figs. 2I–J). In contrast, its expression within the pNT was expanded
both laterally and caudally towards the node region (10/11; Figs. 2I–J′).
Of note, Neurog2 was also absent from the epibranchial placodes
(10/11; Figs. 2I–J). The ectopic expression of Neurog2 in the pNT could
be a consequence of an increase in RA activity, as in chick ectopic
FGF signalling has been shown to repress the expression of some of
the components of the RA signalling pathway (Diez del Corral et al.,
2003; Olivera-Martinez and Storey, 2007; see introduction). This is,
however, unlikely to be the case here since the pattern of RA activity
using the RA-responsive transgene, Rare-lacZ was similar in controls
(n=6) and embryos cultured in the presence of 5×10−5M SU5402 (n=5)
(Figs. 2K, L). These results thus suggest that FGF and RA signalling
pathways regulate in an opposite manner Neurog2 early expression,
independently of each other.
To test the role of Shh on the onset of Neurog2 expression, embryos
were incubated with an active form of Shh protein (5×10−8 M Shh-N)
orwith 10−4M cyclopamine, an inhibitor of Smoothened, a component
of the Shh signalling pathway (Incardona et al., 1998). Neurog2
expression was comparable in control and Shh-N treated embryos
(n=20 and n=11, respectively; data not shown). In contrast, a fraction
of embryos incubated with cyclopamine displayed a marked decrease
or complete loss of Neurog2 expression (5/14) compared to control
embryos (n=6) (Figs. 2M, N). This suggests that the Hedgehog sig-
nalling pathway is required for early expression ofNeurog2. We further
conﬁrmed this ﬁnding by analysing Neurog2 expression in Shh
mutants. Neurog2 expression was completely absent from the pNT
and the prospective diencephalon of 5–7ss Shhmutants (3/3) although
it was present in the placode regions (Figs. 2O, O′, Q, and Q′). At 12ss,
Neurog2 expression remained absent from the pNTand the prospective
diencephalon while a low level of Neurog2 expression was detectable
in the caudal neural tube (2/2; Figs. 2P, R). Thus, our results reveal a
new role for Hedgehog signalling pathway in the initiation of spinal
neurogenesis through the regulation of Neurog2 expression.
Together, these ﬁndings indicate that RA, FGF and Shh signalling
pathways, known to modulate spinal neurogenesis, provide positive
and negative inputs into the regulation of one single gene in the pNT.
Notably, Neurog2 expression displays different requirements for the
three signalling pathways in different parts of the nervous system.
This observation suggests that early Neurog2 expression results, as at
later embryonic stages, from the modular activity of several
enhancer elements (Scardigli et al., 2001; Simmons et al., 2001).
RA, FGF and Shh signals regulate Neurog2-E2 and Neurog2-798
enhancer activities
We next asked whether the signalling pathways modulating
Neurog2 early expression directly regulate Neurog2 transcription. For
this, we examined the activity at the onset of neurogenesis of several
regulatory elements that drive Neurog2 expression in different
domains of the ventral spinal cord at E10.5 (Scardigli et al., 2001).We found that one of these elements, Neurog2-E2, drives expression
of the lacZ reporter gene in a pattern identical to the early expression
of Neurog2 (Figs. 3A and 4A, B, D, and E). Other spinal Neurog2
elements had no activity at this stage (data not shown). Similar to
Neurog2 expression, Neurog2-E2 activity ﬁrst appears in scattered
cells of the anterior pNT at 5ss and this expression extends to the
neural tube and the diencephalon as development proceeds (Figs.
4A, A′, B, B′, D, and E). In contrast to Neurog2 expression, however,
Neurog2-E2 activity was not observed in the epibranchial placodes,
the rhombencephalon and the midbrain at E8.5 and E9.5 (Figs. 4A, B,
D, and E and data not shown). We then divided the E2 element into
four fragments (Neurog2-E2.1- Neurog2-E2.4, see Materials and
methods) and generated transient transgenic embryos with these
regions. Only Neurog2-E2.2:: lacZ transgenic embryos (n=3) dis-
played a robust lacZ expression pattern similar to that of Neurog2-E2
in the pNT and the developing spinal cord at E8.5 (data not shown).
Phylogenic footprinting of the Neurog2-E2.2 sequence using PromAn
(Lardenois et al., 2006) identiﬁed a 798 base pair (bp) sequence in the
Neurog2-E2.2 element (Neurog2-798; Fig. 3A) located 4507 bp 5′ to
the initiation codon that is highly conserved in the mouse, rat, dog,
chimpanzee and human genomes (615 bp conserved out of 798 bp).
We tested the activity of the Neurog2-798 sequence by transgenesis
and found that it was similar to Neurog2-E2 enhancer activity in E8.5
and E9.5 transgenic embryos (Figs. 4C, C′, and F; Fig. 5B; data not
shown).
We then investigated whether the activity of Neurog2-E2 and
Neurog2-798 elements were modulated by RA, FGF and Shh
signalling. For this, we cultured early somite-stage Neurog2-E2::
lacZ and Neurog2-798:: lacZ transgenic embryos in the presence of
inhibitors of RA, FGF and Shh signalling pathways. Incubation of
transgenic embryos with 5×10−6 M BMS493 led to the loss of
reporter gene expression in the neural tube of both Neurog2-E2:: lacZ
embryos (9/9) and Neurog2-798:: lacZ embryos (6/6) compared to
controls (n=11 and n=9, respectively; Figs. 4G, H and Suppl. Fig. 2).
This indicates that RA signalling is essential for the activity of the
Neurog2 regulatory elements as it is for Neurog2 expression.
Following incubation with 5×10−5 M SU5402, we observed a caudal
expansion of lacZ-positive cells within the pNT in both Neurog2-E2::
lacZ embryos (3/3) and Neurog2-798:: lacZ embryos (4/5) compared
to vehicle treated embryos (n=3 and n=8, respectively; Figs. 4I, J and
Suppl. Fig. 2). This is similar to the effect of FGF inhibition on
Neurog2 expression and indicates that FGF signalling acts in the
same manner on the Neurog2 regulatory elements. Finally, the
presence of 10−4 M cyclopamine in the culture medium led to a
decrease in lacZ expression in Neurog2-E2:: lacZ embryos (8/9) and
Neurog2-798:: lacZ embryos (7/8) compared to controls (n=13 and
n=12, respectively; Figs. 4K, L and Suppl. Fig. 2). This demonstrates
that Shh is required for the activity of the Neurog2 elements.
Cyclopamine treatments were much more efﬁcient in disrupting the
activity of the transgenes (Neurog2-E2: 88% and Neurog2-798: 87%)
than that of Neurog2 endogenous expression (35% and see above).
One possible explanation for this discrepancy is the difference of the
genomic context between these constructs. It is very likely that
another enhancer(s) element(s) outside the Neurog2-E2 element
contributes independently of Shh signalling with the Neurog2-798
element to the positive regulation of Neurog2 early expression.
Together these data show that Neurog2-E2 and Neurog2-798
elements are responsive to RA, FGF and Shh signals similar to the
endogenous Neurog2. This strongly suggests that the expression of
Neurog2 in the forming neural tube is mediated by the Neurog2-
798 enhancer element.
RA and Shh signals converge at the level of Neurog2-798 enhancer
We next determined whether the Neurog2-798 element was
regulated directly by RA, FGF and Shh signalling pathways. For this, we
Fig. 3. Description of the Neurog2-798 enhancer element. (A) Schematic representation of Neurog2-E2:: lacZ and Neurog2-798:: lacZ constructs. The lower bar indicates the relative
position of the putative binding sites for Rar/Rxr heterodimers, Gli and Cdx transcription factors within the Neurog2-798 element. The numbers corresponds to the number of bp
between each binding sites. (B) Schematic representation of the different transgenic constructs described in the present work. All contained the endogenous Neurog2 promoter (np)
except 798_βglob:: lacZ which contained the Human βglobin promoter. (C) Comparison of the sequences of the putative binding sites for Rar, Gli and Cdx transcription factors of the
Neurog2-798 element between Mus musculus (Mm), Rattus norvegicus (Rn), Canis familiaris (Cf), Homo sapiens (Hs) and Pan troglodytes (Pt). The upper sequences represent
consensus binding sites, the lower line (mt) point mutations (red letters) generated at these sites and the black boxes the conservation between the sequences.
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acting downstream of these signalling pathways. Using the Matinspec-
tor programandGenomatix transcription factorweightmatrices (http://
www.genomatix.de), we identiﬁed in the Neurog2-798 sequence two
putative RA responsive elements (Rares) (type 2; DR2 and type 5; DR5),
one putative Gli binding site and one putative Cdx site, which are
conserved in the mouse, rat, dog, chimpanzee and human genomes
(Figs. 3A, C). Interestingly, Cdx genes have been reported to mediate the
activity of the FGF, Wnt and RA signalling pathways on Hox gene
regulation in the posterior embryo (Lohnes, 2003).
We next examined the role of these putative binding sites on
Neurog2-798 activity. For this, we analysed the expression of reporter
in transgenic mice harbouring Neurog2-798:: lacZ transgenes contain-
ing mutations in the binding sites that are expected to disrupt
transcription factor binding (Figs. 3B, C). lacZ expression in transgenic
embryos with a mutation in the Cdx binding site (Neurog2-798Cdxmt::
lacZ) was identical to that found in embryos with aWT transgene (Fig.
5A–C′). This shows that the Cdx binding site is not required for
Neurog2-798 enhancer activity. In contrast, mutation of the Gli
binding site (Neurog2-798Glimt) resulted in absence of lacZ expression
in the pNT (8/8) and the neural tube (7/8) of early somite-stage
embryos (Fig. 5A). One of the Neurog2-798Glimt:: lacZ transgenic
embryos showed weak lacZ expression in the neural tube (Fig. 5D, D′).
This result thus shows that an intact Gli binding site is necessary forthe full activity of Neurog2-798 sequence. To determine whether Gli
proteins can physically interact with this binding site we performed
electromobility shift assays (EMSA). A myc tagged Gli protein
(Stamataki et al., 2005) can indeed bind speciﬁcally in vitro to an
oligonucleotide corresponding to the surrounding sequences of the
Gli binding site of Neurog2-798 (Fig. 5E, see legend for details).
We also explored the function of the two Rares by generating
transgenic mice harbouring point mutations in the Rare-DR2
(Neurog2-798DR2mt:: lacZ), the Rare-DR5 (Neurog2-798DR5mt::
lacZ) or in both Rares (Neurog2-798DR2DR5mt:: lacZ). None of the
transgenic mice harbouring mutation(s) in the Rare displayed any
expression of the reporter gene (Fig. 5A and data not shown)
showing that Neurog2-798 enhancer activity requires the two Rares.
We next tested by EMSA the ability of the Rare-DR5 and Rare-DR2
sequences to bind in vitro to Rar and retinoic X receptor (Rxr)
heterodimers. We used receptors deleted in the activation domain
(AB domain; RarΔAB/RxrΔAB) since the binding to Rare sequences is
independent of this domain (Germain et al., 2002). We found that
Rare-DR5 oligonucleotides bind, albeit weakly, to RarbΔAB/RxrgΔAB
heterodimers (Fig. 5G). In contrast, the Rare-DR2 sequence was
unable to bind signiﬁcantly RarbΔAB/RxrgΔAB heterodimers (Fig. 5F,
see legend for details). Together, the EMSA experiments and the
transgenic analysis suggest that the two Rares may work in a
cooperative manner, the binding of the Rare-DR5 being a prerequisite
Fig. 4. RA, Shh and FGF signalling pathways modulate the activity of the Neurog2-798 regulatory element. (A–F) The activity of Neurog2-E2:: lacZ and Neurog2-798:: lacZ in transgenic
mice visualized using ISH for lacZ (B, C′) or WM X-gal staining (E, F) recapitulates Neurog2 early expression seen in Neurog2KIlacZ/+ embryos (A, A′, and D). (G–L) In embryo cultures
(see Fig. 2), addition of 5×10−6 M BMS 493 or 10−4 M cyclopamine is sufﬁcient to markedly reduce the activity of the Neurog-798::lacZ transgene (G, H, K, L), whereas reducing FGF
signalling using 5×10−5 M SU5402 expands caudally the element activity (I, J). (asterisk) node; (s1) last formed somite.
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we cannot exclude the possibility that factors others than Rar/Rxr
heterodimers bind to the Rare-DR2 binding site.
Discussion
The roles of multiple functional signalling pathways, including RA,
Shh and FGF, in the control of the development of the spinal cord have
been extensively studied. However, the mechanisms of integration of
these signals at the level of neural precursors remained poorly
deﬁned. Conceptually, signalling pathways could directly interact to
cross-regulate each other’s pathway. Alternatively, these signals could
be integrated at the level of the transcriptional regulation of individual
genes. Our present study demonstrates that the later mode of sig-
nalling integration is responsible for the regulation of the expression
of a key determinant of spinal neurogenesis, Neurog2. We propose
that this mechanism can be responsible in part for the precise tem-poral and spatial organization of neuronal subtype identities within
the vertebrate spinal cord.
Our data show that the Neurog2-798 enhancer element is res-
ponsible for the early expression of Neurog2 and that the activity of
this element is modulated by RA, Shh and FGF signalling pathways.
First, our ﬁndings provide several lines of evidence for a strict
requirement of RA and Shh signals for the enhancer element activity.
Activated by these signals, the downstream Rar/Rxr heterodimers and
Gli transcription factors act most probably through the identiﬁed
Rares and Gli binding site and trigger Neurog2 expression. Second, the
analysis of embryos cultured for a short period of time in the presence
of an FGF receptor inhibitor suggests that FGF signals play a role in the
restriction of the Neurog2 expression domain via modifying the
activity of the Neurog2-798 enhancer element. Intriguingly, no
conserved binding sites for known downstream components of the
FGF signalling pathway have been identiﬁed within the enhancer
element, raising the issue of the identity of the transcriptional
Fig. 5. Two RA response elements and one Gli binding site are necessary for the activity of the Neurog-798 element. (A) Summary of the activity of theWT and mutated transgenes at
different stages after ISH (E8.5) or X-gal staining (E9.5–E10.5). Insertions represent independent transgene insertions monitored in transient (T) or stable (S) transgenic embryos. (nd)
not determined. (B–D′) WM ISH for lacZ showing that Neurog2-798Cdxmt enhancer activity (C, C′) recapitulates Neurog-798 activity (B), whereas Neurog2-798Glimt is barely
expressed within the Neurog2 domain in the neural tube (D, D′). (E) EMSAs performed withWTor mutated Gli oligonucleotides (Gli-Neurog2; Gli-mt) incubated with a myc tagged Gli
recombinant protein (Gli-med). The complexes (arrows) formed by the Gli-Neurog2 oligonucleotides and the Gli proteins are speciﬁc. First, they can be displaced by an 100-fold molar
excess of control Gli-myf5 oligonucleotides (lane 3) or Gli-Neurog2 oligonucleotides (lane 4). Second, the complexes are also displaced and accumulate in the well in the presence of
the anti-myc antibody (9E10) (lane 6) but not in the presence of the anti-HA antibody (lane7). Third, Gli-mt is unable to form a complex with the Gli-med (lane 9). Of note, the
addition of an 100-fold molar excess of Gli-mt oligonucleotides can although only partially, displace the Gli-Neurog2/Glimed complexes (lane 5). This suggests that the Gli-mt
oligonucleotide retains a weak binding activity to the Gli-med. This differs from the results obtained by Gustafsson et al., 2002, probably because the sequences surrounding the core
Gli binding site used in their study differs from the oligonuleotide used here. (F, G) EMSAs performedwith control Rare-DR2 or DR5 oligonucleotides (DR2-ctl, DR5-ctl) incubated with
heterodimers of recombinant RarbΔAB/RxrgΔAB proteins and an 100-fold molar excess of DR2-ctl (F, lane 3), DR2-Neurog2 (F, lane 4), DR2-Neurog2-mt (F, lane 5), DR5-ctl (G, lane 3),
DR5-Neurog2 (G, lane 4), DR5-Neurog2-mt (G, lane5) oligonucleotides. DR5-Neurog2 binds speciﬁcally RarbΔAB/RxrgΔAB heterodimers as an excess of DR5-ctl or DR5-Neurog2 but
not DR5mt-Neurog2 competes for the DR5-ctl labelled oligonucleotides (G). This binding is of weak afﬁnity since the labelled DR5-Neurog2 oligonucleotides are unable to bind
RarbΔAB/RxrgΔAB heterodimers. On the contrary, DR2-Neurog2 does not speciﬁcally bind RarbΔAB/RxrgΔAB heterodimers, as an excess of either DR2-Neurog2 or DR2mt-Neurog2 is
able to compete similarly the labelled DR2-ctl oligonucleotides (F). (asterisk) node; (s1) last formed somite.
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the modulation of Neurog2 expression by FGF signalling involves
cross-talks between FGF and other signalling pathways. A range of
evidence suggest, for instance, that FGFs can inhibit quite rapidly the
response of neural cells to Shh signalling in vitro (Fogarty et al., 2007)
and ex vivo (Diez del Corral et al., 2003). In our experimental condition
however, this mechanism is unlikely to account for the restriction of
Neurog2-798 activity and of Neurog2 expression. Indeed, in mouse
embryos the blockade of FGF signalling for 6 h does not increase
signiﬁcantly the activity of Shh signalling monitored by Gli1 expres-
sion (10/13) (VR, ILR, PD; in preparation). Similarly, our results suggest
that the effects of inhibiting FGF signalling on Neurog2 expression do
not result from a caudal expansion of RA activity. In agreement with
these results, a recent study in mouse reported that the caudal
boundary of RA activity monitored by the expression of a Rare-lacZ
transgene is unchanged in mouse embryos depleted of FGF activity in
the caudal structures from 6–7ss onwards (Wahl et al., 2007). Finally,
the ‘salt and pepper’ pattern of activity of the Neurog2-798 element
could be reminiscent of a regulation by the Notch-mediated lateral
inhibition process as it has been described at later stages (Bertrand et
al., 2002). This input would allow the reﬁnement of Neurog2 early
expression to a few scattered cells within the pNT and the newly
formed neural tube and preserves a pool of progenitors in an
uncommitted state. We identiﬁed at the 5′ end of the Neurog2-798
element a conserved putative binding site (or Nbox) for the Notch
downstream component Hes. In a pilot experiment we tested whether
this binding site is involved in the regulation of Neurog2-798 element
activity 6 h after its electroporation in chick spinal cord. The activity of
the Neurog2-798 element deleted for the Nbox and of the WT element
was similar (n=6 and n=30, respectively), strongly suggesting that the
identiﬁed Nbox is not required for the early regulation of Neurog2-798
element. Therefore, as for the FGF signalling, the sequences and
transcriptional modulators underlying the regulation of Neurog2
expression via Neurog2-798 enhancer element by Delta-Notch signal-
ling pathway still remain to be characterized.
FGF signallingmaintains the undifferentiated state of a pool of self-
renewing progenitors around the node during the elongation of the
caudal structures and inhibits their migration within more anterior
tissue. In this context, could the restriction of Neurog2 expression via
FGF signals contribute to the known functions of FGF in this area? Fate
map analyses in chicken and mouse embryos show that neural and
somitic progenitors overlap in the ectoderm lateral and caudal to the
node (Brown and Storey, 2000; Cambray and Wilson, 2002, 2007;
Psychoyos and Stern, 1996; Schoenwolf, 1992). In this region, FGF
signalling via FGFR1 controls mesoderm cell fate and adhesive
properties of the primitive streak cells (Ciruna and Rossant, 2001). As
Neurog2 has been shown to regulate the migration properties of
cortical neurons (Ge et al., 2006; Hand et al., 2005), it is tempting to
hypothesise that Neurog2 regulation mediated by FGFs could control
the progression of precursor cells from the pNT to the neural tube.
Videomicroscopy and cell tracing experiments on Neurog2 mutant
embryos would be required to conﬁrm this hypothesis. In addition, in
the spinal cord FGF signalling controls negatively the expression of
ventral patterning genes and the process of neural differentiation via
genes such as Pax6 or NeuroM and Neurog1, respectively (Bertrand et
al., 2000; Diez del Corral et al., 2002, 2003; Novitch et al., 2003;
Olivera-Martinez and Storey, 2007). We show in this study that in the
mouse embryo,Neurog2 is the proneural gene that temporally controls
the commitment and the process of differentiation of spinal progeni-
tors from the 5ss onwards (Fig. 1). We propose that FGF signalling by
negatively regulating Neurog2 expression in the node region keeps the
neural progenitors in an uncommitted state and prevent neurogenesis
from occurring. This negative regulation could, therefore, permit the
maintenance of progenitors in the domain of high FGF signalling.
The strict requirement of the Rares and Gli binding site for Neurog2
induction raises thequestion ofwhether the integration of the activity ofmultiple transcription factors acting downstreamof extracellular factors
is a major mechanism underlying the genomic circuitry that deﬁnes the
development of tissues. Surprisingly, only few studies have directly
addressed this point in an in vivo context. In the ﬂy, a unique
combination of downstream components of signalling pathways
together with transcription factors specify distinct cell fates (Flores et
al., 2000; Halfon et al., 2000). In the mouse, the combination of Gli and
Lef/Tcf binding sites regulates either in an antagonistic manner the
expression of Nkx2.2 in the motor neuron progenitor domain in the
spinal cord (Lei et al., 2006) or in a synergistic manner the expression of
Myf5 in themuscle progenitors in the epaxial domain of the developing
somites (Borello et al., 2006). Using a high-throughputmethod, Hallikas
and coll. identiﬁed combinations of Gli and Lef/Tcf binding sites in
conserved regulatory sequences of many genes suggesting that the
integration of Shh and Wnt signalling pathways may be widely used to
control gene expression during development (Hallikas et al., 2006).
However, experimental data on speciﬁc enhancer elements are still
needed to determine the function of these binding sites. A recent study
described the regulation of Cdx1 in paraxial mesoderm during early
mouse embryogenesis by RA andWnt signals. The authors further show
the cooperative requirement of Rare and Lef/Tcf binding sites tomediate
the full induction of Cdx1 transcription (Pilon et al., 2007).
Our ﬁndings describe for the ﬁrst time the cooperation between
Rar/Rxr heterodimers and Gli proteins at the level of a single enhancer
andwe hypothesise that this speciﬁc cooperation could bewidely used
during neurogenesis for the generation of ventral neuronal subtypes.
Remarkably, both RA and Shh signalling are required for the establish-
ment of a large set of HD and bHLH genes in the ventral neural tube
(Lupo et al., 2006). RA activity triggers the program of generic neural
differentiation (Diez del Corral et al., 2003; Molotkova et al., 2005;
Novitch et al., 2003; Wilson et al., 2004) and regulates directly or
indirectly Hox gene expression (Bel-Vialar et al., 2002; Liu et al., 2001).
Rar/Rxr heterodimers thus, are likely to be generic activators of
transcription in distinct domains along the AP axis of the neural tube
while the gradient of Gli activity along the DV axis throughout the
neural tube (Stamataki et al., 2005) gives a spatial instructive infor-
mation to ventral progenitors. Indeed, human and mouse embryonic
stem cells require both RA and Shh signals to differentiate into motor
neurons (Li et al., 2005;Wichterle et al., 2002). Furthermore, in the E8.5
embryos similarly to endogenous Neurog2 expression, Neurog2-798
activity localises to the ventral spinal cord (Fig. 4E). At a later stage
(E10.5) Neurog2-798 activity recapitulates only in part Neurog2
endogenous expression and localises to the progenitor domains of the
motor neurons and the p2 interneurons (Suppl. Fig. 3 and data not
shown). In addition,mutations of theRaresorGli binding sites abolish or
severely reduceNeurog2-798 activity at all stages observed (E8.5–E10.5,
Fig. 5A, Suppl. Fig. 3), suggesting that these binding sites are also
required for the activity of the enhancer in the motor neuron and p2
interneuron progenitor domains. The underlying mechanism by which
Rar/Rxr heterodimers and Gli proteins regulateNeurog2 transcription in
the nucleus remains unknown. Interestingly, experiments performed on
cell lines or fromnuclear extracts showed that both transcription factors
upon activation of the corresponding pathways interact with key
transcriptional activators such as CBP and the Mediator complex and
strongly promote transcription (Dilworth et al., 2000; Zhou et al., 2006).
It is therefore tempting to hypothesise that these transcription factors
cooperate in recruiting these chromatin modiﬁers and/or components
of the basic transcription machinery to the Neurog2-798 enhancer
element and that this cooperation would be necessary to initiate
Neurog2 transcription (Pozzi et al., 2006).
In conclusion, our analysis has revealed that three regional signals
cooperate at the level of a single enhancer and are responsible for the
early expression of Neurog2 in the posterior embryo. We also show
that this gene plays a key role during the commitment of spinal
progenitors. Hence, we anticipate that the combinatorial transcrip-
tional activity of several signals is likely to be a general mechanism
480 V. Ribes et al. / Developmental Biology 321 (2008) 470–481underlying the temporally controlled generation of unique cell
subtypes during vertebrate development.
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